Phibro Animal Health Corporation (PAHC) - Stock Analysis

Last updated: Jul 26, 2026

Research Idea

Research content for general circulation. Not individualized advice. Methodology & Disclosures

Phibro Animal Health exhibits strong earnings growth, margin expansion, cash flow strength, and a 42% price surge over the last month, making it a hot short-term idea with a solid fundamental and technical growth profile.

Loading chart data...

Idea window: 9/2/2025 – 9/9/2025Sector: Healthcare

AI Analyst Overview

Last Price
$36.95
Market Cap
$1.47B
1D Return
+1.59%
YTD Return
-0.46%

Loading chart data...

Valuation Metrics

P/E
15.5
P/B
4.1
P/S
1.0
EV/EBITDA
9.4
Div Yield
1.32%

Price Behavior

6.0

Key Price Behavior Insights: • Higher lows • Resistance cap • Support hold Support Level: $33.00 / $31.40 Resistance Level: $34.52 PAHC's last month price action is constructive, with higher lows above $33.00, support at $31.40, and resistance near $34.52, but upside likely needs a clear breakout above resistance.

constructive
rangebound

Sentiment & News

5.0

Key News Insights: • Upside Potential • Favorable Revisions • Options Activity PAHC is attracting sustained value-focused attention from analysts and traders, with favorable earnings revisions, projected upside, and a spike in options activity supporting a constructive near-term sentiment.

valueplay
volatility
AI

AI Summary

6.0
Neutral

PAHC should be viewed less as a cheap laggard and more as a company showing a real operating inflection, with broad Animal Health growth, Mineral Nutrition support, raised guidance, and better liquidity, but investors should stay cautious until free cash flow improves and Brazil's antimicrobials regulation and weak Performance Products no longer cap the rerating.

Inflection
Regulation
CashFlow
AI summary updated 3 days ago

Description

Phibro Animal Health Corporation manufactures and sells a range of animal health and mineral nutrition products for livestock, operating through Animal Health, Mineral Nutrition, and Performance Products segments. Its portfolio includes pharmaceutical treatments and vaccines for poultry, swine and cattle, nutritional additives and trace mineral formulations, plus specialty ingredients used in non-food industries. The company distributes products to integrators, feed manufacturers and distributors across North America, Latin America, Europe, the Middle East, Africa and the Asia Pacific from its headquarters in Teaneck, New Jersey.

Idea History

DateCloseTickerCompanySummaryStatusP/L
Sep 2Sep 9PAHCPhibro Animal Health Corporation
Phibro Animal Health exhibits strong earnings growth, margin expansion, cash flow strength, and a 42% price surge over the last month, making it a hot short-term idea with a solid fundamental and technical growth profile.
Closed+12.8%
Research content for educational purposes only. Not investment advice. All decisions are your responsibility.